Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fulminant hepatitis in an asymptomatic chronic carrier of hepatitis B virus mutant after withdrawal of low-dose methotrexate therapy for rheumatoid arthritis.

× No keyword cloud information.

14 in total

Review 1. [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors: D Meyer-Olson; K Hoeper; R E Schmidt
Journal: Z Rheumatol Date: 2010-12 Impact factor: 1.372

Review 2. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

Authors: L H Calabrese; N N Zein; D Vassilopoulos
Journal: Ann Rheum Dis Date: 2006-04-20 Impact factor: 19.103

3. Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.

Authors: Charlie Laohapand; Emvalee Arromdee; Tawesak Tanwandee
Journal: Hepatol Int Date: 2015-01-15 Impact factor: 6.047

Review 4. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations.

Authors: Shunsuke Mori; Shigetoshi Fujiyama
Journal: World J Gastroenterol Date: 2015-09-28 Impact factor: 5.742

5. Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs.

Authors: Jing Tan; Jingguo Zhou; Pan Zhao; Jing Wei
Journal: Clin Rheumatol Date: 2012-04-28 Impact factor: 2.980

6. Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.

Authors: Akihiro Tamori; Tatsuya Koike; Hitoshi Goto; Shigeyuki Wakitani; Masahiro Tada; Hiroyasu Morikawa; Masaru Enomoto; Masaaki Inaba; Tatsuya Nakatani; Masayuki Hino; Norifumi Kawada
Journal: J Gastroenterol Date: 2011-01-19 Impact factor: 7.527

Review 7. Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.

Authors: Venessa Pattullo
Journal: World J Hepatol Date: 2015-05-08

Review 8. Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention.

Authors: Masaru Kato; Tatsuya Atsumi
Journal: Rheumatol Int Date: 2015-11-16 Impact factor: 2.631

Review 9. Prevention and management of hepatitis B virus reactivation in cancer patients.

Authors: Ka-Shing Cheung; Wai-Kay Seto; Ching-Lung Lai; Man-Fung Yuen
Journal: Hepatol Int Date: 2016-01-06 Impact factor: 6.047

10. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors: K Visser; W Katchamart; E Loza; J A Martinez-Lopez; C Salliot; J Trudeau; C Bombardier; L Carmona; D van der Heijde; J W J Bijlsma; D T Boumpas; H Canhao; C J Edwards; V Hamuryudan; T K Kvien; B F Leeb; E M Martín-Mola; H Mielants; U Müller-Ladner; G Murphy; M Østergaard; I A Pereira; C Ramos-Remus; G Valentini; J Zochling; M Dougados
Journal: Ann Rheum Dis Date: 2008-11-25 Impact factor: 19.103